Expression cloning of a protective Leishmania antigen
- PMID: 7725103
- DOI: 10.1126/science.7725103
Expression cloning of a protective Leishmania antigen
Abstract
Parasite-specific CD4+ T cells have been shown to transfer protection against Leishmania major in susceptible BALB/c mice. An epitope-tagged expression library was used to identify the antigen recognized by a protective CD4+ T cell clone. The expression library allowed recombinant proteins made in bacteria to be captured by macrophages for presentation to T cells restricted to major histocompatibility complex class II. A conserved 36-kilodalton member of the tryptophan-aspartic acid repeat family of proteins was identified that was expressed in both stages of the parasite life cycle. A 24-kilodalton portion of this antigen protected susceptible mice when administered as a vaccine with interleukin-12 before infection.
Similar articles
-
Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major.J Exp Med. 1997 Oct 6;186(7):1137-47. doi: 10.1084/jem.186.7.1137. J Exp Med. 1997. PMID: 9314562 Free PMC article.
-
[LACK protein of Leishmania major: a pivotal antigen in the immune relation between host and parasite].Sante. 1997 Nov-Dec;7(6):425. Sante. 1997. PMID: 9503502 French. No abstract available.
-
The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose, intradermal challenge.J Immunol. 2001 Apr 15;166(8):5122-8. doi: 10.4049/jimmunol.166.8.5122. J Immunol. 2001. PMID: 11290794
-
Activation of skin dendritic cells by immunostimulatory DNA.Springer Semin Immunopathol. 2000;22(1-2):45-54. doi: 10.1007/s002810000027. Springer Semin Immunopathol. 2000. PMID: 10944799 Review. No abstract available.
-
Susceptibility to infectious diseases: Leishmania as a paradigm.J Infect Dis. 1999 Mar;179 Suppl 2:S305-8. doi: 10.1086/513843. J Infect Dis. 1999. PMID: 10081500 Review.
Cited by
-
Comparative evaluation of two vaccine candidates against experimental leishmaniasis due to Leishmania major infection in four inbred mouse strains.Clin Vaccine Immunol. 2009 Nov;16(11):1529-37. doi: 10.1128/CVI.00153-09. Epub 2009 Sep 2. Clin Vaccine Immunol. 2009. PMID: 19726616 Free PMC article.
-
Homeostatic competition among T cells revealed by conditional inactivation of the mouse Cd4 gene.J Exp Med. 2001 Dec 17;194(12):1721-30. doi: 10.1084/jem.194.12.1721. J Exp Med. 2001. PMID: 11748274 Free PMC article.
-
Global distribution of treatment resistance gene markers for leishmaniasis.J Clin Lab Anal. 2022 Aug;36(8):e24599. doi: 10.1002/jcla.24599. Epub 2022 Jul 9. J Clin Lab Anal. 2022. PMID: 35808933 Free PMC article. Review.
-
KSAC, the first defined polyprotein vaccine candidate for visceral leishmaniasis.Clin Vaccine Immunol. 2011 Jul;18(7):1118-24. doi: 10.1128/CVI.05024-11. Epub 2011 Jun 1. Clin Vaccine Immunol. 2011. PMID: 21632891 Free PMC article.
-
Kinetoplastid Membrane Protein-11 as a Vaccine Candidate and a Virulence Factor in Leishmania.Front Immunol. 2015 Oct 13;6:524. doi: 10.3389/fimmu.2015.00524. eCollection 2015. Front Immunol. 2015. PMID: 26528287 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials